Noah
Domain-specific AI for pharma, biotech and medical professionals
About Noah
Noah is built for a field where an uncited answer is worthless. In pharmaceutical, biotech and medical work, a claim without a source cannot be used in a regulatory submission, a clinical decision, an investment memo or a publication, no matter how plausible it sounds. General assistants produce fluent text with no verifiable provenance, which is precisely the wrong shape for this audience. Noah grounds every output in PubMed, clinical guidelines, patents and professional databases, and returns cited reports rather than conversational answers.
The corpus is the product: more than a hundred million research articles, clinical trials, guidelines, patents and financial reports. That combination is unusual and deliberate, since a real question in this sector rarely stays in one domain. Assessing a therapeutic area means reading the science, the trial landscape, the patent position and the commercial filings together, and those normally live in four separate expensive subscriptions. The workflow is also distinctive: rather than answering immediately, Noah asks targeted clarifying questions first to lock scope, constraints and assumptions, then plans the work. Plans are annual and credit-metered across three tiers.
Ask your question. Rather than answering straight away, Noah asks a few targeted clarifying questions to fix the scope, constraints and assumptions, then plans the workflow before executing, which is how a competent analyst would handle an ambiguous brief rather than guessing at it. It then works across the corpus, spanning research articles, clinical trials, guidelines, patents and financial reports, and produces a decision-ready report with citations attached to every claim. Because the output is designed as a deliverable rather than a chat response, it can go into the work it was commissioned for. Credits meter usage, from 600 monthly on the entry tier to 10,000 at the top.
- •Citations on Every Claim - Grounded output with attached sources, which is the only usable form in this field
- •100M+ Source Corpus - Research articles, clinical trials, guidelines, patents and financial reports
- •Cross-Domain Coverage - Science, trials, IP and commercial filings together rather than in four separate subscriptions
- •Clarification Before Answering - Locks scope, constraints and assumptions first, then plans the workflow
- •Decision-Ready Reports - Deliverables rather than chat responses
- •Domain-Specific - Built for pharma, biotech and medical rather than adapted from a general assistant
- •Three Credit Tiers - 600, 2,000 or 10,000 credits monthly depending on usage
- •Free Trial and Referral Credits - Try before committing, with credits for invited colleagues
For researchers, medical affairs teams, regulatory professionals and biotech investors who need answers they can cite in work that will be scrutinised. It suits competitive and landscape analysis, where the patent and financial coverage alongside the science is the differentiator. Clinicians looking up guidelines get sourced answers rather than fluent guesses. The clarification-first workflow suits complex questions rather than quick lookups. Note the annual billing, so evaluate against real questions during the trial before committing to a year.
Pricing
$0 - $199.90/mo
- Basic$0/mo
- Starter$14.90/mo
- Pro$49.90/mo
- Elite$199.90/mo
- TeamNot listed
From the vendor pricing page, 2026-09-21
